![](https://www.lachmanconsultants.com/wp-content/uploads/2020/04/iStock-1210596217.jpg)
COVID-19 Variant Mutations Could Impact Test Results
Yesterday, the FDA published a document (here) detailing potential impact on the performance of specific COVID-19 detection tests for the Omicron variant as well as other variants of SARS-CoV-2. The FDA listed tests that may have reduced ability to detect the SARS-CoV-2 Omicron variant and provided a list of thirty‑three sites at which this test […]